The UN Commission considers to bring ketamine under the control of the 1971 Convention on Psychotropic Substances contrary to WHO recommendations. The 58th Session of the UN Commission on Narcotic Drugs (CND) in March 2015 has been asked to consider a Chinese proposal to place ketamine – an essential medicine used for anaesthesia – in Schedule I of the 1971 Convention (E/CN.7/2015/7 and E/CN.7/2015/81). Ketamine is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine under any of the 1971 treaty schedules will reduce its availability and further deepen the already acute crisis of global surgery.
Reflections upon this year’s CND are mixed. On the one hand, some states went further than ever before in openly challenging the current regime on the grounds that, after a century, it needs modernising. That the government of Uruguay is currently considering a domestic policy on cannabis that would put it in breach of the Single Convention shows that, in one instance at least, we have moved beyond rhetoric and posturing.
The Commission on Narcotic Drugs (CND) in Vienna will decide next week between two opposite proposals by China and the WHO about international control of ketamine, an essential anaesthetic in human and veterinary medicine. China originally proposed bringing ketamine under the 1971 Convention’s most severe control regime of Schedule I, which would dramatically affect its availability for surgery in poor rural settings and emergency situations. The WHO Expert Committee reviewed all the evidence and advised against any international control of ketamine, arguing it would trigger a public health disaster.
In 2009, the President of Bolivia, Evo Morales Ayma, sent a letter to the General Secretary of the United Nations, Ban Ki Moon, in which the Government of Bolivia proposed to amend article 49 paragraphs 1 c) and 2 e) of the Single Convention on Narcotic Drugs of 1961. From Bolivia´s point of view, the international community holds in its hands a historic opportunity to correct a misconception regarding coca leaf chewing by eliminating both paragraphs of the Single Convention.
Bolivian President Evo Morales believes that in 2012 the United Nations will finally agree that chewing of coca leaves is a legal ancient tradition of all people living in the Andes. Bolivia signed an agreement with the United Nations in 1961 that gave the country 25 years to eradicate the growing of coca. “I am convinced that next year we will win this international ‘fight’ for the recognition of chewing coca leaves as a tradition of peoples in Latin America, living in the Andes,” Morales said in an interview
Minister of Industry, Investment and Commerce, Anthony Hylton, says Jamaica intends to lead a charge in the United Nations to effect changes to the international treaties concerning marijuana. The aim is to change the schedule class of marijuana in light of scientific studies that have proven its therapeutic benefits and medicinal value. "Jamaica intends to participate, and to lead, if necessary, a process in the United Nations to have those treaties amended," Hylton said.
A proposal that is about to come before the UN to restrict global access to ketamine, a drug abused in rich countries, would deprive millions of women of lifesaving surgery in poor countries, according to medicines campaigners.
In a dispute that pits the war on drugs against global health needs — and one UN agency against another — a pair of Canadian researchers is spearheading a last-ditch bid to keep a widely used anesthetic from being declared an illicit narcotic.
Ketamine is an essential medicine used for anaesthesia. It is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine will leave these populations with no alternative anaesthesia for essential surgery, and will further deepen the already acute crisis of global surgery.
The article reviews the status of khat, the most recent plant based psychoactive substance to reach a global market, and considers policy making processes in general and the framework of drug control in particular. The risk assessment and classification of psychoactive drugs is a contested arena where political, economic and moral agendas collide, leaving countries that have banned khat, with significant social costs. To best manage the risks arising from the increasing availability of khat it is therefore suggested to draft a regulatory framework with clear objectives and guiding principles.
The global war on drugs has failed, with devastating consequences for individuals and societies around the world. Fifty years after the initiation of the UN Single Convention on Narcotic Drugs, and 40 years after President Nixon launched the US government’s war on drugs, fundamental reforms in national and global drug control policies are urgently needed.
This presentation gives a short overview of legislative reforms in Europe and Latin America that provide lessons learned in practice about less punitive approaches intended to reduce drug-related harm to the individual and society. Evidence suggests that fears that softening drug laws and their enforcement would lead to sharp increases in drug use, have proven untrue.
In March 2009, Evo Morales sent his formal request to the Secretary General Bang Ki Moon to delete articles 49(c) and 49(e) of the 1961 UN Single Convention that explicitly mention that "coca leaf chewing must be abolished with twenty-five years from the coming into force of this Convention" (which happened in December 1964). The request will be discussed on Thursday, 30 July, at the annual meeting of the UN Economic and Social Council (ECOSOC). Putting this request on the ECOSOC agenda is a required procedure for amendment proposals. It is under Agenda item 14 (d), Narcotic drugs, General Segment (see the Note of Secretary General).
The upcoming United Nations General Assembly Special Session on Drugs (UNGASS) in 2016 is an unprecedented opportunity to review and re-direct national drug control policies and the future of the global drug control regime. As diplomats sit down to rethink international and domestic drug policy, they would do well to recall the mandate of the United Nations, not least to ensure security, human rights and development.